New Market Research Report: Argentina Pharmaceuticals & Healthcare Report Q2 2015

Despite economic activity forecast to continue to decline over the medium - term, Argentina's gradual transition towards more pragmatic and market-friendly economic policies will likely benefit key economic sectors in the long-term, including the pharmaceutical industry. We sustain our view that undervalued local drugmakers could be acquisition targets for foreign firms willing to enhance their footprint in the region as the economy stabilizes . On the upside, the rise of non-communicable diseases will sustain growing demand for medicines, while improved coordination between the pharmaceutical industry and a skilled scientific workforce in biotechnology and basic research will continue to set the ground for longer term opportunities. However, price controls and lax intellectual property protection will continue to weigh on the market potential.

Full Report Details at
- http://www.fastmr.com/prod/956827_argentina_pharmaceuticals_healthcare_report_q2.aspx?afid=301

Headline Expenditure Projections

Pharmaceuticals: ARS49.89bn (USD6.08bn) in 2014 to ARS54.63bn (USD5.78bn) in 2015; +9.5% in local currency terms and -5.0% in US dollar terms. Forecast broadly in line with the previous quarter.

Healthcare: ARS269.08bn (USD32.81bn) in 2014 to ARS305.47bn (USD32.32bn) in 2015; +13.5% in local currency terms and -1.5% in US dollar terms. Forecast broadly in line with the previous quarter.

Risk/Reward Index : In Q2 2015, Argentina slides one ranking position to 7th out of 18 markets for the Americas region in BMI's Risk/Reward Index (RRI) matrix. The downgrade is due to decelerating economic activity affecting market growth. Argentina's overall score is driven by a large pharmaceutical market (market expenditure score of 14.0 out of 20), significant urbanization leading to better access to healthcare (urban/rural split score of 8.0 out of 8) and an increasing pensionable population (scoring 4.8 out of 8), but dragged down by poor policy enforcement (scoring 1.4 out of 7) and lax intellectual property protection (patent respect score of 2.1 out of 7).

Key Trends And...

The Argentina Pharmaceuticals & Healthcare Report features Business Monitor International (BMI)'s forecasts for drugs and healthcare expenditure and imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

BMI's Argentina Pharmaceuticals & Healthcare Report provides industry professionals, strategists, company executives, investors, analysts and sales/marketing heads with independent forecasts and competitive intelligence on the Argentina pharmaceutical and healthcare industry.

Key Benefits

* Benchmark BMI's pharmaceutical and healthcare market forecasts for Argentina, to test other views - a key input for successful budgeting and strategic business planning in the Argentinian pharmaceutical and healthcare market.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Bulgaria Pharmaceuticals & Healthcare Report Q2 2015
- South Korea Pharmaceuticals & Healthcare Report Q2 2015
- Peru Pharmaceuticals & Healthcare Report Q2 2015
- Nigeria Pharmaceuticals & Healthcare Report Q2 2015
- Mexico Pharmaceuticals & Healthcare Report Q2 2015